drugset / Trial / NCT02528175

Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer

NCT02528175

NaSingle-groupOpen-labelTreatment

Summary

This pilot study hypothesizes that hyperthermia delivered via magnetic resonance-guided focused ultrasound (MRg-FU) is technically feasible and can be safely used in combination with concurrent reirradiation and chemotherapy for the treatment of recurrent rectal cancer. Twenty recurrent rectal cancer patients who are not candidates for surgery will be recruited for hyperthermia treatment delivered via MRg-FU concurrent with reirradiation and oral chemotherapy.

Timeline

Start
2015-04
Primary completion
2021-04
Completion
2022-04

Drugs

EvaluationDrugModalityDoseRoute
Background Capecitabine Small molecule Oral

Indications